FDA wants yet more data on Takeda diabetes drug alogliptin

Article Date: 26/04/2012 10:00
FDA wants yet more data on Takeda diabetes drug alogliptin

Vacancy Search

Quick job search

Advanced Search

Latest News

Lundbeck CEO falls on his sword over share gift

Lundbeck CEO falls on his sword over share gift

AZ gets EU approval for COPD combo

AZ gets EU approval for COPD combo

UK's MRC links with China's Yabao in Parkinson's deal

UK's MRC links with China's Yabao in Parkinson's deal

BioMarin snaps up Prosensa for around $840m

BioMarin snaps up Prosensa for around $840m

Merck & Co unveils NewLink Ebola deal, Japan filing

Merck & Co unveils NewLink Ebola deal, Japan filing

New ICR chief's three-pronged attack on cancer

New ICR chief's three-pronged attack on cancer

Interview – Admedus aims to build a business in the gaps

Some areas in medtech are contested fiercely – with billions of dollars at stake, huge multinationals slug it out, producing new products with tiny advantages over existing tech and hoping...

Weekly Market Movers (to 21 Nov 2014)

EvaluatePharma’s EventAnalyzer delivers a weekly global round up of key events driving company valuations.

Official launch for long-term conditions alliance

Official launch for long-term conditions alliance

AZ spends $200M to expand US biologics site

AZ spends $200M to expand US biologics site
more news